These free AI tools will help you with your calendar, writing tasks, customer service, and much more. Let's dig in.

I rate Bio-Rad (NYSE:BIO) with a buy rating. I start by mentioning that the low growth perspective is the negative aspect.

The Berenberg economics team led by Holger Schmieding produced this striking chart, showing how interest-rate expectations ...

The U.S. stock market has seen a broad rebound over the past month, with a recovery across sectors following the tariff ...

The KSE 100 index is down by 16% from its April record. Till May 8th, it was reported that as much as Rs 820 billion worth of ...

The research, published in Nature Human Behavior, analyzed MRI scans from over 1,000 children to map how different brain ...